Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Picoplatin Efficacy After Relapse (SPEAR)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
Poniard Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00465491
First received: April 23, 2007
Last updated: April 13, 2009
Last verified: April 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)